A detailed history of First Trust Advisors LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 291,941 shares of REGN stock, worth $203 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
291,941
Previous 362,305 19.42%
Holding current value
$203 Million
Previous $381 Million 19.41%
% of portfolio
0.3%
Previous 0.4%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1024.09 - $1201.76 $72.1 Million - $84.6 Million
-70,364 Reduced 19.42%
291,941 $307 Million
Q2 2024

Aug 13, 2024

BUY
$883.2 - $1071.19 $22.8 Million - $27.7 Million
25,833 Added 7.68%
362,305 $381 Million
Q1 2024

May 13, 2024

SELL
$902.69 - $993.35 $26.6 Million - $29.3 Million
-29,478 Reduced 8.06%
336,472 $324 Million
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $152 Million - $173 Million
195,902 Added 115.2%
365,950 $321 Million
Q3 2023

Nov 13, 2023

BUY
$692.45 - $844.37 $5.84 Million - $7.12 Million
8,430 Added 5.22%
170,048 $140 Million
Q2 2023

Aug 14, 2023

SELL
$700.03 - $830.35 $43.4 Million - $51.5 Million
-62,057 Reduced 27.74%
161,618 $116 Million
Q1 2023

May 15, 2023

BUY
$680.49 - $826.97 $16.3 Million - $19.8 Million
23,995 Added 12.02%
223,675 $184 Million
Q4 2022

Feb 09, 2023

SELL
$705.89 - $766.39 $179 Million - $194 Million
-253,607 Reduced 55.95%
199,680 $144 Million
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $31.4 Million - $39.6 Million
54,716 Added 13.73%
453,287 $312 Million
Q2 2022

Aug 12, 2022

BUY
$548.35 - $738.84 $124 Million - $167 Million
225,696 Added 130.55%
398,571 $236 Million
Q1 2022

May 13, 2022

SELL
$595.12 - $698.43 $18.3 Million - $21.5 Million
-30,812 Reduced 15.13%
172,875 $121 Million
Q4 2021

Feb 08, 2022

BUY
$543.48 - $670.97 $3.24 Million - $4.01 Million
5,969 Added 3.02%
203,687 $129 Million
Q3 2021

Nov 15, 2021

BUY
$574.03 - $680.96 $14.6 Million - $17.3 Million
25,468 Added 14.79%
197,718 $120 Million
Q2 2021

Aug 16, 2021

SELL
$472.8 - $558.54 $854,349 - $1.01 Million
-1,807 Reduced 1.04%
172,250 $96.2 Million
Q1 2021

May 14, 2021

BUY
$446.73 - $548.2 $5.42 Million - $6.65 Million
12,136 Added 7.5%
174,057 $82.4 Million
Q4 2020

Feb 02, 2021

SELL
$478.3 - $607.98 $96.7 Million - $123 Million
-202,221 Reduced 55.53%
161,921 $78.2 Million
Q3 2020

Nov 05, 2020

BUY
$544.75 - $658.21 $2.77 Million - $3.34 Million
5,081 Added 1.42%
364,142 $204 Million
Q2 2020

Jul 22, 2020

BUY
$493.32 - $643.92 $53.7 Million - $70.1 Million
108,792 Added 43.47%
359,061 $224 Million
Q1 2020

May 06, 2020

SELL
$336.18 - $494.43 $18.9 Million - $27.8 Million
-56,285 Reduced 18.36%
250,269 $122 Million
Q4 2019

Feb 03, 2020

BUY
$274.13 - $376.51 $2.83 Million - $3.89 Million
10,321 Added 3.48%
306,554 $115 Million
Q3 2019

Nov 04, 2019

SELL
$273.46 - $318.39 $13.9 Million - $16.2 Million
-50,727 Reduced 14.62%
296,233 $82.2 Million
Q2 2019

Jul 30, 2019

SELL
$299.6 - $414.82 $4.08 Million - $5.64 Million
-13,602 Reduced 3.77%
346,960 $109 Million
Q1 2019

May 09, 2019

BUY
$372.08 - $439.57 $25.9 Million - $30.5 Million
69,493 Added 23.88%
360,562 $148 Million
Q4 2018

Feb 07, 2019

BUY
$335.82 - $403.04 $869,437 - $1.04 Million
2,589 Added 0.9%
291,069 $109 Million
Q3 2018

Oct 25, 2018

BUY
$351.14 - $408.51 $35.3 Million - $41.1 Million
100,492 Added 53.46%
288,480 $117 Million
Q2 2018

Aug 02, 2018

BUY
$284.6 - $344.99 $11.3 Million - $13.8 Million
39,879 Added 26.93%
187,988 $64.9 Million
Q1 2018

Apr 23, 2018

BUY
$315.82 - $393.78 $8.4 Million - $10.5 Million
26,584 Added 21.88%
148,109 $51 Million
Q4 2017

Feb 08, 2018

SELL
$358.63 - $469.95 $9.96 Million - $13.1 Million
-27,786 Reduced 18.61%
121,525 $45.7 Million
Q3 2017

Oct 24, 2017

BUY
$431.38 - $504.0 $64.4 Million - $75.3 Million
149,311
149,311 $66.8 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.